| 注册
首页|期刊导航|中国药理学通报|miRNAs与肝细胞癌的相关性研究进展

miRNAs与肝细胞癌的相关性研究进展

孙嘉玲 文彬 孙海涛 陈冠新 贺松其

中国药理学通报2017,Vol.33Issue(4):445-449,5.
中国药理学通报2017,Vol.33Issue(4):445-449,5.DOI:10.3969/j.issn.1001-1978.2017.04.001

miRNAs与肝细胞癌的相关性研究进展

Research progress of relevance between miRNAs and hepatocellular carcinoma

孙嘉玲 1文彬 2孙海涛 1陈冠新 1贺松其1

作者信息

  • 1. 南方医科大学中医药学院,广东 广州 510515
  • 2. 中国人民解放军四五八医院中医科,广东 广州 510602
  • 折叠

摘要

Abstract

Hepatocellular carcinoma(HCC)is one of the most common malignancies worldwide.Due to the difficulty of diagnosis in the early stage of HCC, most HCCs are diagnosed in intermediate-advanced stage.Moreover, the high invasion, metastasis and recurrence rate of HCC result in the high mortality of HCC.MicroRNAs(miRNAs) are a class of highly conserved, endogenous, small, non-coding ,single stranded RNA with the length of 22 nucleotides.There are plentiful of miRNAs in liver.MiRNAs not only can regulate the growth and development of liver, but also are closely related to the formation of HCC.In the process of HCC formation, miRNAs could function as oncogenes or tumor suppressor genes to regulate multiple biological processes related to HCC, including cell differentiation,proliferation,tumorigenesis,angiogenesis,invasion,and metastasis.With the intensive study of molecular mechanisms of miRNAs in the process of HCC formation, increasingly studies have revealed that miRNAs could become sensitive biomarkers and effective therapeutic targets for HCC.

关键词

miRNAs/肝细胞癌/致癌基因/抑癌基因/诊断/治疗

Key words

miRNAs/hepatocellular carcinoma/oncogenes/tumor suppressor genes/diagnosis/therapy

分类

医药卫生

引用本文复制引用

孙嘉玲,文彬,孙海涛,陈冠新,贺松其..miRNAs与肝细胞癌的相关性研究进展[J].中国药理学通报,2017,33(4):445-449,5.

基金项目

国家自然科学基金资助项目(No 81573808) (No 81573808)

广东省中医药局资助项目(No 20151038) (No 20151038)

中国药理学通报

OA北大核心CSCDCSTPCD

1001-1978

访问量0
|
下载量0
段落导航相关论文